Literature DB >> 14614453

AuroraA overexpression overrides the mitotic spindle checkpoint triggered by nocodazole, a microtubule destabilizer.

Ying Jiang1, Yongke Zhang, Emma Lees, Wolfgang Seghezzi.   

Abstract

AuroraA, a mitotic kinase, is reported to be amplified and overexpressed in a variety of human tumors. Active mutants of AuroraA can transform mouse fibroblasts and form tumors in nude mice. However, the mechanism behind this oncogenic potential remains elusive. In this study, we investigated the consequences of AuroraA overexpression and showed that increased AuroraA levels compromise the mitotic spindle checkpoint triggered by nocodazole, a microtubule polymerization inhibitor. This is accomplished by disrupting the proper assembly of the mitotic checkpoint complex at the level of the Cdc20-BubR1 interaction. As a result, the spindle checkpoint complex fails to form and cells progress through mitosis without proper arrest in response to nocodazole. This ability to override the mitotic spindle checkpoint was found to be independent of AuroraA kinase activity. We conclude that maintenance of a functional balance between AuroraA and mitotic checkpoint proteins is essential for the proper progression through mitosis. This study therefore offers a possible explanation of how deregulation of AuroraA can contribute to genetic instability and tumorigenesis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14614453     DOI: 10.1038/sj.onc.1206873

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  17 in total

1.  Novel E3 ligase component FBXL7 ubiquitinates and degrades Aurora A, causing mitotic arrest.

Authors:  Tiffany A Coon; Jennifer R Glasser; Rama K Mallampalli; Bill B Chen
Journal:  Cell Cycle       Date:  2012-02-15       Impact factor: 4.534

2.  Suppression of Aurora-A oncogenic potential by c-Myc downregulation.

Authors:  Shangbin Yang; Shun He; Xiaobo Zhou; Mei Liu; Hongxia Zhu; Yihua Wang; Wei Zhang; Shuang Yan; Lanping Quan; Jingfeng Bai; Ningzhi Xu
Journal:  Exp Mol Med       Date:  2010-11-30       Impact factor: 8.718

3.  MLN8054, a small-molecule inhibitor of Aurora A, causes spindle pole and chromosome congression defects leading to aneuploidy.

Authors:  Kara Hoar; Arijit Chakravarty; Claudia Rabino; Deborah Wysong; Douglas Bowman; Natalie Roy; Jeffrey A Ecsedy
Journal:  Mol Cell Biol       Date:  2007-04-16       Impact factor: 4.272

Review 4.  Mitosis as an anti-cancer drug target.

Authors:  Anna-Leena Salmela; Marko J Kallio
Journal:  Chromosoma       Date:  2013-06-18       Impact factor: 4.316

5.  Effects of stable knockdown of Aurora kinase A on proliferation, migration, chromosomal instability, and expression of focal adhesion kinase and matrix metalloproteinase-2 in HEp-2 cells.

Authors:  Hao Zhang; Xuehua Chen; Bingya Liu; Liang Zhou
Journal:  Mol Cell Biochem       Date:  2011-05-18       Impact factor: 3.396

Review 6.  Aurora kinase inhibitors--rising stars in cancer therapeutics?

Authors:  Altaf A Dar; Laura W Goff; Shahana Majid; Jordan Berlin; Wael El-Rifai
Journal:  Mol Cancer Ther       Date:  2010-02-02       Impact factor: 6.261

7.  Glioma pathogenesis-related protein 1 induces prostate cancer cell death through Hsc70-mediated suppression of AURKA and TPX2.

Authors:  Likun Li; Guang Yang; Chengzhen Ren; Ryuta Tanimoto; Takahiro Hirayama; Jianxiang Wang; David Hawke; Soo Mi Kim; Ju-Seog Lee; Alexei A Goltsov; Sanghee Park; Michael M Ittmann; Patricia Troncoso; Timothy C Thompson
Journal:  Mol Oncol       Date:  2012-12-31       Impact factor: 6.603

8.  Mitotic Origins of Chromosomal Instability in Colorectal Cancer.

Authors:  W Brian Dalton; Vincent W Yang
Journal:  Curr Colorectal Cancer Rep       Date:  2007-04

9.  Initial testing of the aurora kinase A inhibitor MLN8237 by the Pediatric Preclinical Testing Program (PPTP).

Authors:  John M Maris; Christopher L Morton; Richard Gorlick; E Anders Kolb; Richard Lock; Hernan Carol; Stephen T Keir; C Patrick Reynolds; Min H Kang; Jianrong Wu; Malcolm A Smith; Peter J Houghton
Journal:  Pediatr Blood Cancer       Date:  2010-07-15       Impact factor: 3.167

10.  Aurora kinase-C-T191D is constitutively active mutant.

Authors:  Jabbar Khan; Sanaullah Khan; Sobia Attaullah; Ijaz Ali; Shahid Niaz Khan
Journal:  BMC Cell Biol       Date:  2012-03-26       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.